Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Heike Kostka"'
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 10, Iss 11, Pp 1195-1203 (2008)
Epigenetic changes provide a frequent mechanism for transcriptional silencing of genes in cancer cells. We previously established that epigenetic mechanisms are important for control of group IIA phospholipase A2 (PLA2G2A) gene transcription in human
Externí odkaz:
https://doaj.org/article/373450de247c4421b7f6bbaffc7aa59b
Autor:
Mario Menschikowski, Albert Hagelgans, Eugene Gussakovsky, Heike Kostka, Elena L Paley, Gabriele Siegert
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 10, Iss 3, Pp 279-286 (2008)
Upregulation of group IIA phospholipase A2 (sPLA2-IIA) correlates with prostate tumor progression suggesting prooncogenic properties of this protein. Here, we report data on expression of three different sPLA2 isozymes (groups IIA, V, and X) in norma
Externí odkaz:
https://doaj.org/article/fe71da3bb6ae4dce9fe5551f275d77dd
Autor:
Heike, Kostka, Thomas, Schwarz, Sebastian, Schellong, Cornelia, Mix, Eberhard, Kuhlisch, Theodora, Temelkova-Kurktschiev, Elena, Henkel, Carsta, Köhler, Siegmund, Gehrisch, Gabriele, Siegert
Publikováno v:
Blood Coagulation & Fibrinolysis. 14:49-56
Factor V Leiden is a well-known risk factor for venous thrombosis. The dual role of factor V as a coagulatory and anticoagulatory cofactor permits the assumption that further mutations in the factor V gene are of importance in the study of the risk o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317b9dbdd7ca1361eabf90adc5ed561c
https://doi.org/10.1097/00001721-200301000-00009
https://doi.org/10.1097/00001721-200301000-00009
Autor:
Heike Kostka, Sebastian Tuve, Marc Schmitz, Julia Fantana, Marco Berning, Martin Aringer, Uta Oelschlägel, Christiane Jakob, Brigitte Mohr, Martin Bornhauser, Jan Moritz Middeke, Ulrich Sommer, Anne Erler, Gustavo Baretton, Jana Babatz
Publikováno v:
Journal of Bone Marrow Research.
The molecular mechanisms that lead to autoantibody production and autoimmune disease remain poorly defined. Based on a clinical observation in a patient with lupus erythematosus and autoimmune hepatitis we here provide the first evidence that (i) a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95cc73b550c4d0cd7f614e854a0f7ae3
https://doi.org/10.4172/2329-8820.1000147
https://doi.org/10.4172/2329-8820.1000147
Autor:
Florian, Prüller, Reinhard B, Raggam, Harald, Mangge, Martie, Truschnig-Wilders, Eva-Maria, Matzhold, Eva-Christine, Weiss, Barbara, Hasiba, Kelli L, Summers, Wilfried, Renner, Gabriele, Siegert, Heike, Kostka
Publikováno v:
British Journal of Haematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ff866d86d920808bd7e7c69707835a3
https://pubmed.ncbi.nlm.nih.gov/23957718
https://pubmed.ncbi.nlm.nih.gov/23957718